Aug 6, 2026 08:04AM
Aug 4, 2026 01:41PM
Aug 3, 2026 05:13AM
Jun 24, 2026 06:44AM
Jun 11, 2026 12:07PM
Jun 8, 2026 06:08AM
May 19, 2026 09:54AM Piper Sandler on Climb Bio (CLYM): 'Upcoming HV data has the potential to unlock significant value'
May 12, 2026 06:54AM
May 7, 2026 07:45AM
May 5, 2026 07:04AM
May 5, 2026 03:08AM
Apr 21, 2026 05:55AM
Apr 15, 2026 04:13AM
Apr 7, 2026 05:54PM BTIG on Climb Bio (CLYM): FDA fast track for Budoprutug in pMN 'validating event'
Mar 24, 2026 03:58AM
Mar 17, 2026 04:28PM
Mar 10, 2026 04:06PM
Mar 5, 2026 05:30PM
Mar 5, 2026 06:54AM
Feb 13, 2026 03:47AM
Jan 8, 2026 07:05AM Climb Bio begins dosing patients in membranous nephropathy trial
Dec 31, 2025 04:15PM
Dec 30, 2025 03:02PM
Dec 18, 2025 06:47AM
Oct 21, 2025 07:00AM
Oct 16, 2025 06:02AM
Oct 13, 2025 06:37AM
Sep 30, 2025 07:16AM Oppenheimer on Climb Bio (CLYM): 'Positive CLYM116 Reveal Carves Path Forward in IgAN'
Sep 30, 2025 06:06AM
Sep 29, 2025 07:01AM
Aug 15, 2025 08:59AM
Aug 12, 2025 04:24PM
Jun 18, 2025 07:01AM
Jun 6, 2025 06:47AM
May 22, 2025 06:20AM BTIG Starts Climb Bio (CLYM) at Buy
May 14, 2025 05:16PM
Apr 1, 2025 07:03AM
Mar 25, 2025 04:41PM
Feb 24, 2025 07:04AM
Dec 19, 2024 07:03AM
Dec 2, 2024 06:20AM
Nov 15, 2024 12:59AM Climb Bio, Inc. (CLYM) Reports Q3 Loss of $0.13
Oct 11, 2024 12:32PM
Oct 2, 2024 09:01AM

443,764 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All